Create Alert
Watchlist

Aarti Drugs

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹4,316Cr
ROE12.28%
P/E Ratio(TTM)22.86
EPS(TTM)20.54
P/B Ratio3.15
Dividend Yield0.21%
Industry P/E34.34
Book Value148.98
Debt to Equity0.45
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Aarti Drugs

Aarti Drugs Limited is an India-based company that is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates through pharmaceuticals segment. The Company's APIs products include ciprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole and ofloxacin, among others. Its specialty chemicals products include benzene sulphonyl chloride and methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include itraconazole, fluconazole, dabigatran, ticagrelor, sitagliptin and alpha lipoic acid. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SPA.;
Parent OrganisationAarti Drugs Limited
Managing DirectorShri. Rashesh Gogri
NSE SymbolAARTIDRUGS

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
55.22%
Retail And Others
32.58%
Mutual Funds
9.85%
Foreign Institutions
2.26%
Other Domestic Institutions
0.09%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Divi's Laboratories
NA
(0.00%)
70.43
Neuland Laboratories
NA
(0.00%)
98.02
Jubilant Pharmova
NA
(0.00%)
35.29
Acutaas Chemicals
NA
(0.00%)
60.86